These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 15603978)

  • 21. Depot medroxyprogesterone acetate use after peak bone mass is associated with increased bone turnover but no decrease in bone mineral density.
    Walsh JS; Eastell R; Peel NF
    Fertil Steril; 2010 Feb; 93(3):697-701. PubMed ID: 19013564
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The association between depot medroxyprogesterone acetate contraception and bone mineral density in adolescent women.
    Scholes D; LaCroix AZ; Ichikawa LE; Barlow WE; Ott SM
    Contraception; 2004 Feb; 69(2):99-104. PubMed ID: 14759613
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of depot medroxyprogesterone acetate on bone mineral density in adolescent women.
    Zhang MH; Zhang W; Zhang AD; Yang Y; Gai L
    Chin Med J (Engl); 2013 Nov; 126(21):4043-7. PubMed ID: 24229671
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bone mineral density and depot medroxyprogesterone acetate.
    Albertazzi P; Bottazzi M; Steel SA
    Contraception; 2006 Jun; 73(6):577-83. PubMed ID: 16730487
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bone mineral density in women using depot medroxyprogesterone acetate (DMPA) for at least 2 years compared to a control group: a cross sectional study.
    Pongsatha S; Ekmahachai M; Chaovisitsaree S; Suntornlimsiri N; Morakote N
    J Med Assoc Thai; 2009 Oct; 92(10):1263-7. PubMed ID: 19845231
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Both a combined oral contraceptive and depot medroxyprogesterone acetate impair endothelial function in young women.
    Lizarelli PM; Martins WP; Vieira CS; Soares GM; Franceschini SA; Ferriani RA; Patta MC
    Contraception; 2009 Jan; 79(1):35-40. PubMed ID: 19041439
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Longitudinal evaluation of perimenopausal bone loss: effects of different low dose oral contraceptive preparations on bone mineral density.
    Gambacciani M; Cappagli B; Lazzarini V; Ciaponi M; Fruzzetti F; Genazzani AR
    Maturitas; 2006 May; 54(2):176-80. PubMed ID: 16332417
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Levonorgestrel and 17beta-estradiol given transdermally for the prevention of postmenopausal osteoporosis.
    Warming L; Ravn P; Christiansen C
    Maturitas; 2005 Feb; 50(2):78-85. PubMed ID: 15653003
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bone mineral density loss and recovery during 48 months in first-time users of depot medroxyprogesterone acetate.
    Clark MK; Sowers M; Levy B; Nichols S
    Fertil Steril; 2006 Nov; 86(5):1466-74. PubMed ID: 16996507
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biochemical markers of bone turnover in percutaneous vertebroplasty for osteoporotic compression fracture.
    Komemushi A; Tanigawa N; Kariya S; Kojima H; Shomura Y; Tokuda T; Nomura M; Terada J; Kamata M; Sawada S
    Cardiovasc Intervent Radiol; 2008; 31(2):332-5. PubMed ID: 18074174
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of contraceptive use on bone biochemical markers in young women.
    Ott SM; Scholes D; LaCroix AZ; Ichikawa LE; Yoshida CK; Barlow WE
    J Clin Endocrinol Metab; 2001 Jan; 86(1):179-85. PubMed ID: 11231998
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Decreased urinary calcium loss and lower bone turnover in young oral contraceptive users.
    Zittermann A
    Metabolism; 2000 Aug; 49(8):1078-82. PubMed ID: 10954029
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of chronic liver disease on bone mineral density and bone metabolism markers in postmenopausal women.
    Uretmen S; Gol M; Cimrin D; Irmak E
    Eur J Obstet Gynecol Reprod Biol; 2005 Nov; 123(1):67-71. PubMed ID: 16051419
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of the skeletal effects of the progestogens desogestrel and levonorgestrel in oral contraceptive preparations in young women: controlled, open, partly randomized investigation over 13 cycles.
    Hartard M; Kleinmond C; Luppa P; Zelger O; Egger K; Wiseman M; Weissenbacher ER; Felsenberg D; Erben RG
    Contraception; 2006 Nov; 74(5):367-75. PubMed ID: 17046377
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correlations of serum prolidase activity between bone turnover markers and mineral density in postmenopausal osteoporosis.
    Verit FF; Geyikli I; Yazgan P; Celik A
    Arch Gynecol Obstet; 2006 Jun; 274(3):133-7. PubMed ID: 16532321
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Short-term response of bone turnover to low-dose oral contraceptives in exercising women with hypothalamic amenorrhea.
    Vescovi JD; VanHeest JL; De Souza MJ
    Contraception; 2008 Feb; 77(2):97-104. PubMed ID: 18226672
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of oral contraceptive treatment on bone mass acquisition in skeletally immature young female rats.
    Eleftheriades MI; Lambrinoudaki IV; Christodoulakos GE; Gregoriou OV; Economou EV; Kouskouni EE; Antoniou AG; Perrea DN; Dontas IA; Raptou PD; Lyritis GP; Creatsas GC
    Contraception; 2005 May; 71(5):362-71. PubMed ID: 15854638
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bone mineral density in women aged 40-49 years using depot-medroxyprogesterone acetate, norethisterone enanthate or combined oral contraceptives for contraception.
    Beksinska ME; Smit JA; Kleinschmidt I; Farley TM; Mbatha F
    Contraception; 2005 Mar; 71(3):170-5. PubMed ID: 15722065
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased formation of 8-iso-prostaglandin F(2alpha) is associated with altered bone metabolism and lower bone mass in hypercholesterolaemic subjects.
    Mangiafico RA; Malaponte G; Pennisi P; Li Volti G; Trovato G; Mangiafico M; Bevelacqua Y; Mazza F; Fiore CE
    J Intern Med; 2007 Jun; 261(6):587-96. PubMed ID: 17547714
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The combined contraceptive vaginal ring and bone mineral density in healthy pre-menopausal women.
    Massai R; Mäkäräinen L; Kuukankorpi A; Klipping C; Duijkers I; Dieben T
    Hum Reprod; 2005 Oct; 20(10):2764-8. PubMed ID: 15980008
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.